Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?"1 passage
• 'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant.1 passage
• 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients.1 passage
• A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?1 passage
• A Duplicated Gallbladder in a Patient Presenting with Acute Cholangitis. A Case Study and a Literature Review.1 passage
• A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure.1 passage
• A Head CT is Unnecessary in the Initial Evaluation of A Cirrhotic Patient with Recurrent Hepatic Encephalopathy.1 passage
• A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management.1 passage
• A New Paradigm in Gallstones Diseases and Marked Elevation of Transaminases: An Observational Study.1 passage
• A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis.1 passage
• A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2.1 passage
• A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma.1 passage
• A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico-A systematic review and meta-analysis (2008-2019).1 passage
• A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.1 passage
• A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report.1 passage
• A hospital-based study of the prevalence of HBV, HCV, HIV, and liver disease among a low-income population in West Mexico.1 passage
• A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B.1 passage
• A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma.1 passage
• A simple scoring model for predicting early graft failure and postoperative mortality after liver transplantation.1 passage
• A systematic review and meta-analysis of the COVID-19 associated liver injury.1 passage
• A validated risk model for prediction of early readmission in patients with hepatic encephalopathy.1 passage
• ABCB4 disease: Many faces of one gene deficiency.1 passage
• ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.1 passage
• ALBI and PALBI: Novel Scores for Outcome Prediction of Cirrhotic Outpatients Awaiting Liver Transplantation.1 passage
• Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.1 passage
• Accuracy of the BAR score in the prediction of survival after liver transplantation.1 passage
• Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases.1 passage
• Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients.1 passage
• Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment.1 passage
• Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay.1 passage
• Acute Variceal Bleeding: Does Octreotide Improve Outcomes in Patients with Different Functional Hepatic Reserve?1 passage
• Acute hepatitis E mimicking a flare of disease in a patient with chronic autoimmune hepatitis.1 passage
• Acute kidney injury is associated with higher mortality and healthcare costs in hospitalized patients with cirrhosis.1 passage
• Acute liver failure associated with Garcinia cambogia use.1 passage
• Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculenta.1 passage
• Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.1 passage
• Acute-on-chronic liver failure: A comparison of three different diagnostic criteria.1 passage
• Adherence to Appropriate Nutrition in Acute Alcoholic Hepatitis is Low.1 passage
• Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals.1 passage
• Aging impairs fibrosis-4 index after sustained virologic response by direct-acting antivirals in chronic hepatitis C infection.1 passage
• Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis.1 passage
• Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis.1 passage
• Alcohol Consumption Influences Clinical Outcome in Patients Admitted to a Referral Center for Liver Disease.1 passage
• Alcohol and HBV synergistically promote hepatic steatosis.1 passage
• Alcohol and the Liver: The Return of the Prodigal Son.1 passage
• Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America.1 passage
• Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).1 passage
• Alcoholic hepatitis: How far are we and where are we going?1 passage
• Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.1 passage
• Algorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis.1 passage
• Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.1 passage
• Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.1 passage
• Alternative splicing and liver disease.1 passage
• Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19.1 passage
• An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis.1 passage
• An Inexpensive Digital Image Analysis Technique for Liver Fibrosis Quantification in Chronic Hepatitis B Patients.1 passage
• An Integrated Review of the Hepatorenal Syndrome.1 passage
• An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A.1 passage
• An Overview of Liver Transplant Pathology: Data from a Tertiary Referral Centre in Western India.1 passage
• An aqueous extract of Stevia rebaudiana variety Morita II prevents liver damage in a rat model of cirrhosis that mimics the human disease.1 passage
• An autoimmune polyglandular syndrome complicated with celiac disease and autoimmune hepatitis.1 passage
• An unusual type of biliar cyst: A case report.1 passage
• Analysis of the MELD Score Impact in the Outcome of Endovascular Portal Vein Reconstruction.1 passage
• Anaphylaxis preceded by erythema multiforme with sorafenib: First case report.1 passage
• Andrew K. Burroughs: a research hepatologist extraordinaire.1 passage
• Angiogenesis and portal-systemic collaterals in portal hypertension.1 passage
• Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis.1 passage
• Antioxidants benefits in hepatitis C infection in the new DAAs era.1 passage
• Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.1 passage
• Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.1 passage
• Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.1 passage
• Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis.1 passage
• Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma.1 passage
• Artificial liver support system in pediatric acute liver failure due to mushroom poisoning: Case series.1 passage
• Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.1 passage
• Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.1 passage
• Association Between Serum Hemoglobin Levels and Non Alcoholic Fatty Liver Disease in a Mexican Population.1 passage
• Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Cross-sectional Study.1 passage
• Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.1 passage
• Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis.1 passage
• Association between plasma bilirubin and mortality.1 passage
• Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis.1 passage
• Association of Adolescent Obesity with Nonalcoholic Fatty Liver Disease and Related Risk Factors in Xi 'an, China.1 passage
• Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients.1 passage
• Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance.1 passage
• Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis.1 passage
• Association of Parity in Patients with Chronic Liver Disease.1 passage
• Association of a novel TAS2R38 haplotype with alcohol intake among Mexican-Mestizo population.1 passage
• Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.1 passage
• Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).1 passage
• Associations between body mass index and mortality in acute-on-chronic liver failure patients.1 passage
• Atypical Abdominal Pain in a Patient With Liver Cirrhosis.1 passage
• Autochthonous infection with hepatitis E virus related to subtype 3a, France: a case report.1 passage
• Bacterial infections in cirrhosis: Current treatment.1 passage
• Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic.1 passage
• Bile Acid Physiology.1 passage
• Bile Acids and Cancer: Direct and Environmental-Dependent Effects.1 passage
• Bile Acids and Portal Hypertension1 passage
• Bile Acids in Cholestasis and its Treatment.1 passage
• Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and therapeutic advances.1 passage
• Bile Acids in the Treatment of Cardiometabolic Diseases.1 passage
• Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing.1 passage
• Biliary Paracoccidioidomycosis: An Unusual Infection Simulating Malignant Neoplasm.1 passage
• Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.1 passage
• Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016).1 passage
• Boceprevir and telaprevir for chronic genotype 1 hepatitis C virus infection. A systematic review and meta-analysis.1 passage
• Body mass index and alcohol consumption are directly related with liver steatosis. Results from a prospective study of patients referred for hyperferritinemia.1 passage
• Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases.1 passage
• Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study.1 passage
• COVID-19 and the liver: What do we know after six months of the pandemic?1 passage
• CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.1 passage
• Calling a stage-based treatment model for chronic liver diseases in China mainland.1 passage
• Can Prohibitin 1 be a Safeguard against liver disease?1 passage
• Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers.1 passage
• Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosis.1 passage
• Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study.1 passage
• Case Series Regarding Parastomal Variceal Bleeding: Presentation and Management.1 passage
• Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review.1 passage
• Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.1 passage
• Cerebral hemodynamics in the non-alcoholic fatty liver.1 passage
• Challenges in Management of Hepatitis A Virus Epidemiological Transition in Mexico.1 passage
• Characteristics and outcomes of hospitalized patients with Wilson's disease in the United States: A national survey.1 passage
• Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.1 passage
• Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease.1 passage
• Chemotherapy-associated steatohepatitis.1 passage
• Cholangiohydatidosis: an Infrequent Cause of Obstructive Jaundice and Acute Cholangitis.1 passage
• Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma.1 passage
• Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport.1 passage
• Choosing Wisely Canada-Top Five List in Hepatology: Official Position Statement of the Canadian Association for the Study of the Liver (CASL) and Choosing Wisely Canada (CWC).1 passage
• Chronic Hepatitis C Patients with Obesity: Do we Need two Operators for Accurate Evaluation of Liver Stiffness?1 passage
• Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?1 passage
• Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.1 passage
• Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p.1 passage
• Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.1 passage
• Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.1 passage
• Clinical Analysis of Polyethylene Glycol Interferon-α Treatment in 155 Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) Patients.1 passage
• Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience.1 passage
• Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy.1 passage
• Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study.1 passage
• Clinical Presentation and Anatopathologic Finding of a Hepatic Vascular Hamartoma: a Case Report.1 passage
• Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis.1 passage
• Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.1 passage
• Clinical characteristics of liver failure from a systemic cause: A report from an advanced critical care center.1 passage
• Clinical characteristics, predictors, and survival among patients with hepatopulmonary syndrome.1 passage
• Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy.1 passage
• Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases.1 passage
• Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population.1 passage
• Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas.1 passage
• Cohort study: Apparent redundancy of fibrosis assessment in young persons with HCV; development of realistic approaches to break the paradigm.1 passage
• Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience.1 passage
• Comorbidities have a limited impact on post-transplant survival in carefully selected cirrhotic patients: a population-based cohort study.1 passage
• Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1.1 passage
• Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients.1 passage
• Comparing hepatic steatosis distribution patterns between non-alcoholic fatty liver disease and fatty liver disease with chronic hepatitis B by second-harmonic generation/two-photon excited fluorescence method.1 passage
• Comparison of Dynamic Changes Among Various Prognostic Scores in Viral Hepatitis-Related Acute Liver Failure.1 passage
• Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.1 passage
• Complications of liver resection in geriatric patients.1 passage
• Computed Tomography and Magnetic Resonance Imaging Features of Primary and Secondary Hepatic Glycogenosis.1 passage
• Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis c in the era of new oral direct-acting antivirals: A concise review.1 passage
• Congenital Shunts of the Portal Venous System: Case-series of Uncommon Shunts.1 passage
• Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.1 passage
• Contrast-induced acute kidney injury in cirrhotic patients. A retrospective analysis.1 passage
• Controversies in early liver transplantation for severe alcoholic hepatitis.1 passage
• Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key.1 passage
• Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease.1 passage
• Correlation of APRI Index with Metavir Index in Children with Neonatal Cholestasis Without Biliary Atresia.1 passage
• Cost of illness of liver diseases in Japan.1 passage
• Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B.1 passage
• Cross-Talk Between Bile Acids and Gastro-Intestinal and Thermogenic Hormones: Clues from Bariatric Surgery1 passage
• Cryptogenic Cirrhosis and Sitosterolemia: A Treatable Disease If Identified but Fatal If Missed.1 passage
• Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?1 passage
• Cultural Validation of the Transplanted Organ Questionnaire (TOQ) for the Brazilian Population.1 passage
• Cultural validation of the post-Liver transplant quality of life (pLTQ) questionnaire for the Brazilian population.1 passage
• Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort.1 passage
• Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications.1 passage
• Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy.1 passage
• Current concepts in acute liver failure.1 passage
• Cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome.1 passage
• Cystic angiosarcoma of the liver. A previously undescribed neoplasm.1 passage
• Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction.1 passage
• DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.1 passage
• Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.1 passage
• Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: results of Turkish early access program.1 passage
• Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.1 passage
• Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.1 passage
• Detection of hepatitis B activity in HBeAg-negative carriers with normal aminotransferase levels in central Brazil.1 passage
• Diagnosis of liver nodules within and outside screening programs.1 passage
• Diagnosis, surgical treatment and postoperative outcomes of hepatic endometriosis: A systematic review.1 passage
• Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis.1 passage
• Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.1 passage
• Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population.1 passage
• Diastolic dysfunction is associated with low urinary sodium excretion in patients with decompensated cirrhosis.1 passage
• Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients.1 passage
• Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.1 passage
• Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma.1 passage
• Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.1 passage
• Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.1 passage
• Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome.1 passage
• Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients.1 passage
• Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence.1 passage
• Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?1 passage
• Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.1 passage
• Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAM.1 passage
• Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?1 passage
• Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.1 passage
• Drug-induced fatty liver disease: An overview of pathogenesis and management.1 passage
• Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.1 passage
• Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.1 passage
• Early Successes in an Open Access, Provincially Funded Hepatitis C Treatment Program in Prince Edward Island.2 passages
• Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.1 passage
• Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation.1 passage
• Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.1 passage
• Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.1 passage
• Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C.1 passage
• Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.1 passage
• Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B.1 passage
• Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension.1 passage
• Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals.1 passage
• Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C.1 passage
• Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis.1 passage
• Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort study.1 passage
• Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study.1 passage
• Effects of interleukin-4 and interleukin-12B gene polymorphisms on hepatitis B virus vaccination.1 passage
• Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy.1 passage
• Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.1 passage
• Efficacy and Tolerability of Ombitasvir/Paritaprevir/Ritonavir in HCV Genotype 1-infected Elderly Japanese Patients.1 passage
• Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study.1 passage
• Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil.1 passage
• Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.1 passage
• Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus.1 passage
• Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.1 passage
• Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients.1 passage
• EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil.1 passage
• Endoscopic Management of Primary Sclerosing Cholangitis.1 passage
• Endoscopic Therapy is Effective for Recurrent Anastomotic Biliary Strictures after Orthotopic Liver Transplantation.1 passage
• Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis - A meta-analysis.1 passage
• Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis.1 passage
• Enterococcus casseliflavus and Enterococcus gallinarum as causative agents of spontaneous bacterial peritonitis.1 passage
• Epidemiologic features of a large hepatitis C cohort evaluated in a major health system in the western United States.1 passage
• Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.1 passage
• Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment.1 passage
• Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV.1 passage
• Establishment of competitive binding assay to detect and differentiate hepatitis E virus infection.1 passage
• Etiology, outcome and prognostic factors of childhood acute liver failure in a German Single Center.1 passage
• Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.1 passage
• Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil.1 passage
• Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis.1 passage
• Evaluation of response to hepatitis B virus vaccine in adults with human immunodeficiency virus.1 passage
• Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography.1 passage
• Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis.1 passage
• Evaluation the value of markers for prediction of portal vein thrombosis after devascularization.1 passage
• Evidence-Based Medicine and the Problem of Healthy Volunteers.1 passage
• Exercise Capacity and Respiratory Profile in Patients after Orthopedic Liver Transplantation: a Follow-up Study.1 passage
• Exercise capacity of cirrhotic patients with hepatopulmonary syndrome.1 passage
• Expanding TACTICS trial into a different setting in hepatocellular carcinoma.1 passage
• Experience with Sorafenib in 3 Hospitals in Sao Paulo.1 passage
• Expression of Natural Killer Cell Inhibitory Receptors is Associated with Significant Liver Injury in Chronic Hepatitis C in Children.1 passage
• External validation and comparison of six prognostic models in a prospective cohort of HBV-ACLF in China.1 passage
• Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C.1 passage
• Extrahepatic causes of death in cirrhosis compared to other chronic conditions in the United States, 1999-2017.1 passage
• Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis.1 passage
• Factors associated with occupational and non-occupational viral hepatitis infections in Brazil between 2007-2014.1 passage
• Factors associated with recurrence and survival in liver transplant patients with HCC--a single center retrospective study.1 passage
• Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice.1 passage
• Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.1 passage
• Fatty liver and abdominal fat relationships with high C-reactive protein in adults without coronary heart disease.1 passage
• Feasibility of Hepatology-Directed Microwave Ablation in Management of Hepatocellular Carcinoma in North America: A Pilot Project.1 passage
• Fibrates for Primary Biliary Cholangitis: What's All the Hype?1 passage
• Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.1 passage
• FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases.1 passage
• Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.1 passage
• Fighting Mortality in the Waiting List: Liver Transplantation in North America, Europe, and Asia.1 passage
• First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplant.1 passage
• First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico.1 passage
• Fontan-Associated Liver Disease: A Review.1 passage
• Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up.1 passage
• Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.1 passage
• Frequency of hepatitis C virus infection in a single institution in Mexico with a focus on birth-cohort population.1 passage
• From Child-Pugh to MELD score and beyond: Taking a walk down memory lane.1 passage
• GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.1 passage
• GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.1 passage
• Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences.1 passage
• Gastrointestinal neuroendocrine tumor with unresectable liver metastases: an example of multimodal therapeutic approach.1 passage
• Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.1 passage
• Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy.1 passage
• Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease.1 passage
• Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease.1 passage
• Giant hepatocellular adenoma in a previously obese thirteen-year-old boy.1 passage
• Good outcomes of liver transplantation for hepatitis C at a low volume centre.1 passage
• Graft calcification caused by a torsion of the hepatic vein after a living-related donor liver transplantation.1 passage
• Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis.1 passage
• Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis.1 passage
• Granulocyte-colony stimulating factor prevents the development of hepatic steatosis in rats.1 passage
• Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis.1 passage
• HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.1 passage
• HCV antiviral therapy in injection drug users: difficult to treat or easy to cure?1 passage
• HEPLA: A multicenter study on demographic and disease characteristics of patients with hepatitis C in Latin America.1 passage
• HLA Class II-DRB1 Alleles with Hepatitis C Virus Infection Outcome in Egypt: A Multicentre Family-based Study.1 passage
• Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience.1 passage
• Hepatic Abscess Secondary to Stomach Perforation by a Fish Bone: a Rare Cause of Hepatic Abscess.1 passage
• Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature.1 passage
• Hepatic Cyst Compressing The Right Atrial and Ventricular Inflow Tract: An Uncommon Cardiac Complication.1 passage
• Hepatic Echinococcosis with Thoracic Involvement. Clinical Characteristics of a Prospective Series of Cases.1 passage
• Hepatic Hydrothorax.1 passage
• Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.1 passage
• Hepatic immune-mediatedadverseeffects of immune checkpoint inhibitors: analysis of real-life experience.1 passage
• Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis.1 passage
• Hepatic steatosis and respiratory diseases: a new panorama.1 passage
• Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.1 passage
• Hepatitis B and NAFLD: Lives Crossed.1 passage
• Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy.1 passage
• Hepatitis B infection in Mexican adults: Results of a nationally representative survey.1 passage
• Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B.1 passage
• Hepatitis B virus in Lao dentists: A cross-sectional serological study.1 passage
• Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis.1 passage
• Hepatitis C Virus Infection and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis.1 passage
• Hepatitis C and Its Metabolic Complications in Kidney Disease.1 passage
• Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life study.1 passage
• Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence.1 passage
• Hepatitis E Virus Genotype 1 Cases Imported to Portugal from India, 2016.1 passage
• Hepatitis E Virus: Still an Enigma in Mexico.1 passage
• Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?1 passage
• Hepatitis E in Latin America.1 passage
• Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.1 passage
• Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center.1 passage
• Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.1 passage
• Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.1 passage
• Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.1 passage
• Hepatocellular carcinoma, a unique tumor with a lack of biomarkers.1 passage
• Hepatoportal sclerosis related to the use of herbals and nutritional supplements. Causality or coincidence?1 passage
• Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways.1 passage
• Hepatorenal syndrome: Current concepts related to diagnosis and management.1 passage
• Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.1 passage
• High Prevalence of Hepatitis B Subgenotype D4 in Northeast Brazil: an Ancient Relic from African Continent?1 passage
• High Prevalence of ITPA Alleles Associated with Ribavirin-Induced Hemolytic Anemia Among Mexican Population.1 passage
• High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India.1 passage
• High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.1 passage
• High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.1 passage
• High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.1 passage
• Horizon scanning of therapeutic modalities for nonalcoholic steatohepatitis.1 passage
• How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets.1 passage
• Human immunodeficiency virus and the liver: The impact of coinfection with hepatotropic viruses.1 passage
• Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3.1 passage
• Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients.1 passage
• IFNL3 polymorphisms and HCV infection in patients with beta thalassemia.1 passage
• Identification of Matrix Metalloproteinase-2 and 9 as Biomarker of Intrahepatic Cholestasis of Pregnancy.1 passage
• Identification of cholesterol gallstone with two-dimensional gel electrophoresis and mass spectrometry.1 passage
• Identification of mutations in the S gene of hepatitis B virus in HIV positive Mexican patients with occult hepatitis B virus infection.1 passage
• Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, Alberta.1 passage
• Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion.1 passage
• Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.1 passage
• Immunotherapy in hepatocellular carcinoma.1 passage
• Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study.1 passage
• Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese.1 passage
• Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country.1 passage
• Impact of Sustained Viral Response in the Evolution of Minimal Hepatic Encephalopathy: a Prospective Pilot Study.1 passage
• Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review.1 passage
• Impact of psychosocial status on liver transplant process.1 passage
• Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study.1 passage
• Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration.1 passage
• Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals.1 passage
• Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival.1 passage
• Incomplete Kawasaki Disease in an Infant with Cholangitis Post Kasai Surgery for Biliary Atresia.1 passage
• Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico.1 passage
• Increased access to liver transplantation for patients with acute on chronic liver failure after implementation of Share 35 Rule: An analysis from the UNOS database.1 passage
• Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.1 passage
• Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III.1 passage
• Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.1 passage
• Infected hepatic echinococcosis. Clinical, therapeutic, and prognostic aspects. A systematic review.1 passage
• Infection and Predictors of Outcome of Cirrhotic Patients after Emergency Care Hospital Admission.1 passage
• Infection in cirrhosis: A prospective study.1 passage
• Influence of ApoE and FABP2 polymorphisms and environmental factors in the susceptibility to gallstone disease.1 passage
• Insurance status impacts treatment for hepatocellular carcinoma.1 passage
• Inter and intrapatient evolution of hepatitis C virus.1 passage
• Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation.1 passage
• Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.1 passage
• Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.1 passage
• Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients.1 passage
• Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection.1 passage
• Interferon-based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C.1 passage
• Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists' expertise.1 passage
• Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.1 passage
• Intrapulmonary vascular dilation in children with chronic liver diseases: pre- and post-liver transplantation.1 passage
• Introduction of a Standardized Protocol for Cardiac Risk Assessment in Candidates for Liver Transplant - A Retrospective Cohort Analysis.1 passage
• Involvement of the receptor for advanced glycation end products in liver transplantation.1 passage
• Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations.1 passage
• Is intestinal oxidative stress involved in patients with compensated liver cirrhosis?1 passage
• Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?1 passage
• Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction.1 passage
• Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates.1 passage
• Isolated liver disease in a patient with a CFTR genotype F508del/12TG-5T and 470MV: A new face of an old disease.1 passage
• LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV.1 passage
• LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV.1 passage
• LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study.1 passage
• Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.1 passage
• Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism.1 passage
• Laparoscopic Partial ALPPS: Much Better Than ALPPS!1 passage
• Laparoscopic repair of transected right hepatic artery during cholecystectomy: A report of two cases.1 passage
• Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.1 passage
• Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series.1 passage
• Liquid biopsy in chronic liver disease.1 passage
• Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?1 passage
• Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.1 passage
• Liver allografts from donors with peritoneal contamination: report of two cases.1 passage
• Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.1 passage
• Liver disease in pregnancy: Medical aspects and their implications for mother and child.1 passage
• Liver function as a predictor of mortality in COVID-19: A retrospective study.1 passage
• Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients.1 passage
• Liver iron concentration is not raised in patients with dysmetabolic hyperferritinemia.1 passage
• Liver stiffness assessed by transient elastography in patients with β thalassaemia major.1 passage
• Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.1 passage
• Liver transplantation followed by autologous stem cell transplantation for acute liver failure caused by AL amyloidosis. Case report and review of the literature.1 passage
• Liver transplantation in acute liver failure due to Hepatitis B. Two clinical cases.1 passage
• Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry.1 passage
• Liver transplantation in the setting of a spontaneous shunt between superior mesenteric vein and right renal vein.1 passage
• Liver transplantation utilizing a severely fractured graft: every organ counts.1 passage
• Liver-specific case fatality due to chronic hepatitis C virus infection: a systematic review.1 passage
• LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.1 passage
• LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.1 passage
• LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2.1 passage
• LncRNA-Regulated Autophagy and its Potential Role in Drug-Induced Liver Injury.1 passage
• Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p.1 passage
• Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers.1 passage
• Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.1 passage
• Low prevalence of anti-hepatitis E virus IgG antibodies in Tepehuanos in Mexico.1 passage
• Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population.1 passage
• Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures.1 passage
• Lysosomal Acid Lipase Deficiency Leading to Liver Cirrhosis: a Case Report of a Rare Variant Mutation.1 passage
• Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?1 passage
• MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort.1 passage
• MRE in NAFLD: Promising but Further Validation is Required.1 passage
• Management of gastroesophageal varices in cirrhotic patients: current status and future directions.1 passage
• Management of liver metastases of gastrointestinal stromal tumors (GIST).1 passage
• Management strategies for liver fibrosis.1 passage
• Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.1 passage
• Maternal smoking during pregnancy is risk factor for gallbladder disease in offspring during adulthood: a prospective study from UK Biobank.1 passage
• Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations.1 passage
• Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection.1 passage
• Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.1 passage
• Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.1 passage
• Meta-analysis of the clinical value of oxymatrine on sustained virological response in chronic hepatitis B.1 passage
• Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes.1 passage
• Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis.1 passage
• Metastases of Hepatocellular Carcinoma Misdiagnosed as Isolated Hypertrophic Cardiomyopathy.1 passage
• Metastatic cholangiocarcinoma in a patient with undiagnosed Wilson disease.1 passage
• Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.1 passage
• MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.1 passage
• MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A.1 passage
• MicroRNA Profile in Peripheral Blood Mononuclear Cells from Hepatitis B Virus Infected Patients.1 passage
• MicroRNA-124a contributes to glucocorticoid resistance in acute-on-chronic liver failure by negatively regulating glucocorticoid receptor alpha.1 passage
• Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH).1 passage
• Minimal hepatic encephalopathy in cirrhosis- how long to treat?1 passage
• Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.1 passage
• Monosegmental ALPPS after Bilateral Hepatectomy.1 passage
• Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms?1 passage
• More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.1 passage
• Most overweight and obese Indian children have nonalcoholic fatty liver disease.1 passage
• Mucinous Cystic Neoplasm of the Liver or Intraductal Papillary Mucinous Neoplasm of the Bile Duct? A Case Report and a Review of Literature.1 passage
• Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment.1 passage
• Multiple liver lesions in a patient with Budd-Chiari syndrome secondary to polycythemia vera.1 passage
• Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.1 passage
• Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency.1 passage
• Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin.1 passage
• Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV.1 passage
• Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation.1 passage
• N-acetyl cysteine versus standard of care for non-acetaminophen induced acute liver injury: a systematic review and meta-analysis.1 passage
• NAFLD: Challenges and opportunities to address the public health problem in Latin America.1 passage
• NASH: A glance at the landscape of pharmacological treatment.1 passage
• NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection.1 passage
• NRF-2 and nonalcoholic fatty liver disease.1 passage
• Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype.1 passage
• New Insights About Albumin and Liver Disease.1 passage
• New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.1 passage
• New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease.1 passage
• Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population.1 passage
• Nodular Regenerative Hyperplasia Induced by Trastuzumab Emtansine: Role of Emtansine?1 passage
• Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis.1 passage
• Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease.1 passage
• Non-alcoholic fatty liver disease and neurological defects.1 passage
• Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures.2 passages
• Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: Is it an Immuno-Inflammatory Disorder?1 passage
• Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse.1 passage
• Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity.1 passage
• Obesity and liver cancer.1 passage
• Obesity as a cause of hepatocellular carcinoma.1 passage
• Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).1 passage
• Occult Hepatitis B and Other Unexplored Risk Factors for Hepatocellular Carcinoma in Latin America.1 passage
• Occult Hepatitis C Infection Among Hemodialysis Patients: A Prevalence Study.1 passage
• Occult central pontine myelinolysis post liver transplant: A consequence of pre-transplant hyponatremia.1 passage
• Ocular manifestations of liver disease in children: Clinical aspects and implications.1 passage
• Olfactory Function is Affected in Patients with Cirrhosis Depending on the Severity of Hepatic Encephalopathy.1 passage
• One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infection.1 passage
• Osteopontin - A potential biomarker of advanced liver disease.1 passage
• Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases.1 passage
• Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.1 passage
• Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases.1 passage
• Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.1 passage
• Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.1 passage
• Oxidative stress in hepatitis C virus-human immunodeficiency virus co-infected patients.1 passage
• PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.1 passage
• PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population.1 passage
• Papillary in situ and intramucosal adenocarcinoma of the lower third of common bile duct. A report and review of the literature.1 passage
• Paradoxical embolization in TIPS: take a closer look to the heart.1 passage
• Pattern of Vascular Involvement in Egyptian Patients with Budd-Chiari Syndrome: Relation to Etiology and Impact on Clinical Presentation.1 passage
• Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis.1 passage
• Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain.1 passage
• Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155.1 passage
• Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study.1 passage
• Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.1 passage
• Performing thermal ablations for hepatomas - is it a worthy skill for hepatologists?1 passage
• Peritoneal ultrafiltration for refractory fluid overload and ascites due to pulmonary arterial hypertension.1 passage
• Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis.1 passage
• Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.1 passage
• Perspectives on NASH Histology: Cellular Ballooning.1 passage
• Phosphorylation of eIF2α mitigates endoplasmic reticulum stress and hepatocyte necroptosis in acute liver injury.1 passage
• Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review.1 passage
• Plants used for the treatment of icterus (jaundice) in Central India: A review.1 passage
• Plasma transfusion combined with chelating therapy alleviates fulminant Wilson's disease with a single Arg778Leu heterozygote mutation.1 passage
• Platelets level variability during the first year after liver transplantation in the risk prediction model for recipients mortality.1 passage
• Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population.1 passage
• Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?1 passage
• Portal vein thrombosis: what is new?1 passage
• Post-liver transplant outcomes in patients with major psychiatric diagnosis in the United States.1 passage
• Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.1 passage
• Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.1 passage
• Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.1 passage
• Predicting early discharge from hospital after liver transplantation (ERDALT) at a single center: a new model.1 passage
• Predictive role BLVRA mRNA expression in hepatocellular cancer.1 passage
• Predictors and impacts of hospital readmissions following liver transplantation.1 passage
• Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort.1 passage
• Predictors of do-not-resuscitate order utilization in decompensated cirrhosis hospitalized patients: A nationwide inpatient cohort study.1 passage
• Pregnancy in Chronic Liver Disease: Before and After Transplantation.1 passage
• Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.1 passage
• Preserving the organ donor pool and suprahepatic vena cava: Case series of transverse hepatectomy for polycystic liver disease.1 passage
• Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.1 passage
• Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.1 passage
• Prevalence and risk factors of hepatitis C virus infection in the rural northeastern United States.1 passage
• Prevalence in vulnerable population of liver fibrosis identified by transient elastography.1 passage
• Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life.1 passage
• Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients.1 passage
• Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.1 passage
• Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease.1 passage
• Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America.1 passage
• Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?1 passage
• Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.1 passage
• Primary Adenoid Cystic Carcinoma of the Liver: Case Report and Review of the Literature.1 passage
• Primary biliary cholangitis with autoimmune hepatitis features: What's the appropriate criteria to evaluate the treatment-response?1 passage
• Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator.1 passage
• Prognostic Significance of The New Criteria for Acute Kidney Injury in Cirrhosis.1 passage
• Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.1 passage
• Prognostic factors in hepatocellular carcinoma patients with Child-Pugh A liver function after hepatectomy: Not related to the surgical approach.1 passage
• Prognostic value of hepatic encephalopathy for survival of patients with liver failure: A systematic review and meta-analysis.1 passage
• Prognostic value of liver biochemical parameters for COVID-19 mortality.1 passage
• Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.1 passage
• Propranolol for infantile hepatic hemangioendothelioma: Clinical evaluation of drug efficacy and safety using a single-center patient cohort.1 passage
• Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.1 passage
• Prospective study of hepatitis B virus reactivation in patients with hematological malignancies.1 passage
• Pyogenic Liver Abscess Secondary to Foreign Body (Fish Bone) Treated by Laparoscopy: A Case Report.1 passage
• Racial Disparities in Hepatitis C Treatment Eligibility.1 passage
• Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.2 passages
• Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy.1 passage
• Rare Case of Hepatic Endometriosis as an Incidental Finding: Difficult Diagnosis of a Diagnostic Dilemma.1 passage
• Rare biliary cystic tumors: a case series of biliary cystadenomas and cystadenocarcinoma.1 passage
• Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma.1 passage
• Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis.1 passage
• Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics.1 passage
• Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory Drugs.1 passage
• Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy.1 passage
• Recurrent Hyperammonemia After Abernethy Malformation Type 2 Closure: a Case Report.1 passage
• Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside.1 passage
• Relationship of Severity of Hepatitis A with Polymorphisms in Hepatitis A Virus Cellular Receptor 1 (HAVCR1) Gene.1 passage
• Relative Adrenal Insufficiency is Associated with the Clinical Outcome in Patients with Stable Decompensated Cirrhosis.1 passage
• Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit.1 passage
• Requirement of cyclin-dependent kinase function for hepatitis B virus cccDNA synthesis as measured by digital PCR.1 passage
• Rescue Therapy for Genotype-3 DAA Non-responders, Almost all Done.1 passage
• Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection.1 passage
• Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma.1 passage
• Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.1 passage
• Retinoid X Receptor α-Dependent HBV Minichromosome Remodeling and Viral Replication.1 passage
• Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.1 passage
• Right hepatic lobe resection and thrombocytopenia.1 passage
• Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load.1 passage
• Risk and Prognosis of Acute Liver Injury Among Hospitalized Patients with Hemodynamic Instability: A Nationwide Analysis.1 passage
• Risk factors contributing to early infection following transjugular intrahepatic portosystemic shunt in perioperative period.1 passage
• Risk factors for acute kidney injury and 30-day mortality after liver transplantation.1 passage
• Risk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation: A single center experience.1 passage
• Risk factors for early repeat ERCP in liver transplantation patients with anastomotic biliary stricture.1 passage
• Role of CD98 in liver disease.1 passage
• Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis.1 passage
• Roles of diencephalon/mesencephalon homeobox 1 in the development and prognosis of hepatocellular carcinoma.1 passage
• Rotational Thromboelastometry or Conventional Coagulation Tests in Liver Transplantation: Comparing Blood Loss, Transfusions, and Cost.1 passage
• Ruptured hepatocellular carcinoma and non-alcoholic fatty liver disease, a potentially life-threatening complication in a population at increased risk.1 passage
• SARS-CoV-2 another kind of liver aggressor, how does it do that?1 passage
• SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women.1 passage
• STAT3: A key regulator in liver fibrosis.1 passage
• SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient.1 passage
• Safety and Efficacy of Laparoscopic Radiofrequency Ablation for Hepatic Hemangiomas: A Multicenter Retrospective Study.1 passage
• Safety and efficacy of angiographic occlusion of duodenal varices as an alternative to TIPS: review of 32 cases.1 passage
• Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.1 passage
• Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling.1 passage
• Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.1 passage
• Schistosomal portal hypertension: Randomized trial comparing endoscopic therapy alone or preceded by esophagogastric devascularization and splenectomy.1 passage
• Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.1 passage
• Screening for esophageal varices in cirrhotic patients - Non-invasive methods.1 passage
• Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack.1 passage
• Secondary sclerosing cholangitis following major burn.1 passage
• Sensitivity and Specificity of Biochemical Tests for Diagnosis of Intrahepatic Cholestasis of Pregnancy.1 passage
• Serial assessment of hepatic encephalopathy in patients hospitalised for acute decompensation of cirrhosis.1 passage
• Serological and molecular study of Hepatitis E virus in pediatric patients in Mexico.1 passage
• Serum Electrolyte Levels and Outcomes in Patients Hospitalized with Hepatic Encephalopathy.1 passage
• Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.1 passage
• Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure.1 passage
• Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population.1 passage
• Serum ferritin is a biomarker for liver mortality in the Hemochromatosis and Iron Overload Screening Study.1 passage
• Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis.1 passage
• Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy.1 passage
• Silymarin is an ally against insulin resistance: A review.1 passage
• Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection.1 passage
• Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report.1 passage
• Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients: results from a tertiary referral centre.1 passage
• Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant.1 passage
• Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.1 passage
• Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience.1 passage
• Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant: A real-life experience.1 passage
• Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis.1 passage
• Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension.1 passage
• Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis.1 passage
• Spontaneous hepatic rupture during pregnancy in a patient with peliosis hepatis.1 passage
• Stick to Milan: Infeasibility of the Brazil-Milan Criteria in recommending patients with hepatocellular carcinoma for liver transplantation.1 passage
• Successful pregnancy after ileal exclusion in progressive familial intrahepatic cholestasis type 2.1 passage
• Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.1 passage
• Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis.1 passage
• Symptoms of Daytime Sleepiness and Sleep Apnea in Liver Cirrhosis Patients.1 passage
• Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report.1 passage
• TCR Vβ Usage of Peripheral Blood and Liver Infiltrating Lymphocytes in Patients with Chronic Hepatitis B.1 passage
• Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism.1 passage
• Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progression.1 passage
• Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection.1 passage
• Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.1 passage
• The -250G/A and -514C/T Polymorphisms in Hepatic Lipase Gene Promoter Confers an Increased Risk of Hepatocellular Carcinoma in a Chinese Population.1 passage
• The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers.1 passage
• The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma.1 passage
• The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.1 passage
• The Evolving Role of Liver Biopsy in Non-alcoholic Fatty Liver Disease.1 passage
• The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.1 passage
• The Great Chinese Famine Exposure in Early Life and the Risk of Nonalcoholic Fatty Liver Disease in Adult Women.1 passage
• The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients.1 passage
• The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidence.1 passage
• The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib.1 passage
• The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report.1 passage
• The Portuguese Version of the Immunosuppressant Therapy Adherence Scale (ITAS) among Liver Transplant Recipient Patients: Translation and Psychometric Properties.1 passage
• The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids.1 passage
• The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection.1 passage
• The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.1 passage
• The Role of TIPS in patients with Refractory Ascites and Portal Vein Thrombosis.1 passage
• The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure.1 passage
• The Role of the Gut Microbiota in Bile Acid Metabolism.1 passage
• The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review.1 passage
• The White-test helps to reduce biliary leakage in liver resection: a systematic review and meta-analysis.1 passage
• The basis of liver regeneration: A systems biology approach.1 passage
• The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study.1 passage
• The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center.1 passage
• The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.1 passage
• The effect of liver test abnormalities on the prognosis of COVID-19.1 passage
• The effects of hyperthermia on human hepatocellular carcinoma stem and mature cancer cells.1 passage
• The efficacy and safety of entecavir in patients with chronic hepatitis B- associated liver failure: a meta-analysis.1 passage
• The fatigue impact scale for daily use in patients with hepatitis B virus and hepatitis C virus chronic infections.1 passage
• The function of MicroRNA in hepatitis B virus-related liver diseases: from Dim to Bright.1 passage
• The histone variant H3.3 regulates the transcription of the hepatitis B virus.1 passage
• The impact of different infectious complications on mortality of hospitalized patients with liver cirrhosis.1 passage
• The impact of electronic medical record system implementation on HCV screening and continuum of care: a systematic review.1 passage
• The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.1 passage
• The imperative for an updated cirrhosis surgical risk score.1 passage
• The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaHCC after HCV eradication in hemophilia.1 passage
• The limited prognostic value of liver histology in children with biliary atresia.1 passage
• The liver in times of COVID-19: What hepatologists should know.1 passage
• The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem.1 passage
• The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.1 passage
• The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis.1 passage
• The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with hepatocellular carcinoma.1 passage
• The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population.1 passage
• The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy.1 passage
• The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.1 passage
• The regulatory role of microRNA-mRNA co-expression in hepatitis B virus-associated acute liver failure.1 passage
• The relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis C.1 passage
• The relationship between coagulation disorders and the risk of bleeding in cirrhotic patients.1 passage
• The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease.1 passage
• The role of zinc in liver cirrhosis.1 passage
• The treatment of diabetes mellitus of patients with chronic liver disease.1 passage
• Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure.1 passage
• Thrombosis and hemorrhage in the critically ill cirrhotic patients: five years retrospective prevalence study.1 passage
• Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients.1 passage
• Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.1 passage
• Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects.1 passage
• Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant.1 passage
• Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases.1 passage
• Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region.1 passage
• Transfer of peanut allergy from donor to recipient after liver transplant.1 passage
• Transient Elastography vs. Aspartate Aminotransferase to Platelet Ratio Index in Hepatitis C: A Meta-Analysis.1 passage
• Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).1 passage
• Transient hyperglycemia during liver transplantation does not affect the early graft function.1 passage
• Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial.1 passage
• Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.1 passage
• Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil.1 passage
• Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial.1 passage
• Treatment of chronic HBV infection in developing countries.1 passage
• Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features.1 passage
• Turnera diffusa extract attenuates profibrotic, extracellular matrix and mitochondrial markers in activated human hepatic stellate cells (HSC).1 passage
• Twenty-year follow-up of an outbreak of hepatitis C in a small rural town of Argentina: The O'Brien Project.1 passage
• Two Cases of Primary Hepatic Neuroendocrine Tumors and a Review of the Current Literature.1 passage
• Type II Abernethy Malformation in a Patient with Primary Budd-Chiari Syndrome.1 passage
• Undue Elevation of Procalcitonin in Pediatric Paracetamol Intoxication is Not Explained by Liver Cell Injury Alone.1 passage
• Unexpected findings of hepatitis B and delta infection in northeastern Brazil: A public health alert.1 passage
• Urinary Neutrophil Gelatinase-Associated Lipocalin in Cirrhotic Patients with Acute Kidney Injury.1 passage
• Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation Availability.1 passage
• Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.1 passage
• Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease.1 passage
• Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article.1 passage
• Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure.1 passage
• Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C.1 passage
• Utility and safety of tolvaptan in cirrhotic patients with hyponatremia: A prospective cohort study.1 passage
• Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.1 passage
• Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.1 passage
• Validation of prognostic scores for clinical outcomes in cirrhotic patients with acute variceal bleeding.1 passage
• Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients.1 passage
• Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.1 passage
• Vasoconstrictors in hepatorenal syndrome - A critical review.1 passage
• Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.1 passage
• Viewpoint: "Alcohol Consumption in Late Adolescence is Associated with an Increased Risk of Severe Liver Disease Later in Life".1 passage
• Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma.1 passage
• Viral eradication restores normal iron status in chronic hepatitis C patients with abnormal iron studies.1 passage
• Viscoelastic Testing in Liver Disease.1 passage
• Vitamin D Deficiency is not Associated with Fatty Liver in a Mexican Population.1 passage
• Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.1 passage
• Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database.1 passage
• Weekend admissions with ascites are associated with delayed paracentesis: A nationwide analysis of the 'weekend effect'.1 passage
• What constitutes liver failure after transjugular intrahepatic portosystemic shunt creation? A proposed definition and grading system.1 passage
• What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There Any Place for Surgery?1 passage
• Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.1 passage
• Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.1 passage
• Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review.1 passage
• miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro.1 passage